Subcutaneous Monitor 96% Sensitive for AF in Study
February 17, 2010 (Dallas, Texas) — An “insertable” monitor designed primarily for detecting atrial fibrillation (AF), positioned subcutaneously without leads, had a 96% sensitivity and 97% negative predictive value for the arrhythmia in an observational study that compared the device with simultaneous Holter monitoring as the gold standard [1].
The device (Reveal XT, Medtronic, Minneapolis, MN) [...]
